Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Boule Diagnostics

1.22 SEK+0.83 %19/11 16:06
Less than 1K followers

BOUL

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
+0.83 %
-41.02 %
-63.18 %
-63.18 %
-75.25 %
-77.83 %
-87.63 %
-96.79 %
-86.80 %

Boule Diagnostics operates in the medical technology industry and focuses on the development and manufacture of diagnostic instruments for hematology. The company's products are aimed at healthcare institutions and laboratories. The business is global with a main presence in Europe, North America and Asia. Boule Diagnostics was founded in 1956 and is headquartered in Spånga, Sweden.

Read more
Market cap
47.18M SEK
Turnover
77.34K SEK
Revenue
489.6M
EBIT %
4.55 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7/12
2026

Extraordinary general meeting '27

10/2
2027

Annual report '26

27/4
2027

Interim report Q1'27

Regulatory press release2026-11-17 16:59

Finansinspektionen: Korrigering flaggningsmeddelande i Boule Diagnostics AB

Boule Diagnostics
Regulatory press release2026-11-17 16:53

Finansinspektionen: Flaggningsmeddelande i Boule Diagnostics AB

Boule Diagnostics
Regulatory press release2026-11-05 14:48

Finansinspektionen: Flaggningsmeddelande i Boule Diagnostics AB

Boule Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release2026-11-04 08:02

Kallelse till extra bolagsstämma i Boule Diagnostics AB (publ)

Boule Diagnostics
Regulatory press release2026-11-04 08:01

Boule Diagnostics AB beslutar om en fullt säkerställd företrädesemission om cirka 93 MSEK med en övertilldelningsoption om upp till cirka 63 MSEK villkorat av godkännande från extra bolagsstämma

Boule Diagnostics
Regulatory press release2026-11-04 08:01

Boule Diagnostics AB resolves on a fully secured rights issue of approximately MSEK 93 with an over-allotment option of up to approximately MSEK 63 subject to approval by the Extraordinary General Meeting

Boule Diagnostics
Regulatory press release2026-11-04 08:00

Boule Diagnostics renodlar verksamheten mot förbrukningsvaror, service och OEM – avvecklar instrumentverksamheten

Boule Diagnostics
Regulatory press release2026-11-04 08:00

Boule Diagnostics refocuses its operations on consumables, service and OEM – discontinues its instrument business

Boule Diagnostics
Regulatory press release2026-10-23 08:00

Boule Diagnostics delårsrapport Q3 2026

Boule Diagnostics
Regulatory press release2026-10-23 08:00

Boule Diagnostics Interim Report Q3 2026

Boule Diagnostics
Press release2026-10-06 14:00

Boule Diagnostics stärker det långsiktiga strategiska samarbetet i Indien

Boule Diagnostics
Press release2026-10-06 14:00

Boule Diagnostics Strengthens Long-Term Strategic Collaboration in India

Boule Diagnostics
Regulatory press release2026-08-31 16:30

Kommuniké från Boule Diagnostics extra bolagsstämma den 31 augusti 2026

Boule Diagnostics
Regulatory press release2026-08-31 16:30

Bulletin from the Extraordinary General Meeting August 31, 2026 in Boule Diagnostics

Boule Diagnostics
Regulatory press release2026-08-05 16:30

KALLELSE TILL EXTRA BOLAGSSTÄMMA I BOULE DIAGNOSTICS AB

Boule Diagnostics
Regulatory press release2026-07-17 08:00

Boule Diagnostics delårsrapport Q2 2026

Boule Diagnostics
Regulatory press release2026-07-17 08:00

Boule Diagnostics Interim Report Q2 2026

Boule Diagnostics
Regulatory press release2026-06-18 08:30

Boule Diagnostics utser ny verkställande direktör

Boule Diagnostics
Regulatory press release2026-06-18 08:30

Boule Diagnostics appoints new Chief Executive Officer

Boule Diagnostics
Press release2026-05-29 08:30

Boule Diagnostics utser Simonetta Tumbiolo till Interim VD

Boule Diagnostics